Guardian Capital LP (the “Manager”) announces the following regular cash distributions for the period ending November 30, 2025, in respect of the ETF series of the Guardian Capital funds listed below ...
SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended September 30, 2025.